简体中文 | 繁體中文 | English

Divestiture News

2022-03-07 19:06 iCapital® Expands Strategic Partnership With Bank of Singapore
2022-03-07 09:22 Western Union Completes First Closing of its Business Solutions Divestiture
2022-02-09 14:45 Takeda Delivers Strong Third Quarter FY2021 Results and Raises Full-Year Forecast Reflecting Strong Momentum
2022-02-08 19:13 Toshiba Provides Update on Strategic Reorganization to Enhance Shareholder Value
2022-01-24 10:42 McAfee Continues to Provide Leading Online Protection to Consumers
2021-12-16 14:40 Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma
2021-11-17 19:43 Toshiba Announces Strategic Reorganization to Separate Into Three Standalone Companies to Enhance Shareholder Value
2021-10-13 14:33 Consensus Cloud Solutions, Inc. Completes Separation from Ziff Davis, Inc.
2021-09-29 13:58 The Rohatyn Group Partially Divests Shareholding in the IPO of Sansera Engineering Limited on Indian Stock Exchanges
2021-08-05 10:24 Western Union Announces Agreement to Sell Western Union Business Solutions to Goldfinch Partners and The Baupost Group for Approximately $910 Million in Cash
2021-07-27 09:40 ABB to Divest Mechanical Power Transmission Division (Dodge) to RBC Bearings for $2.9 Billion
2021-04-22 09:59 Sale of 60.5% of ENGIE EPS by ENGIE to TCC: ENGIE EPS to Become NHOA
2021-04-07 14:36 Stonepeak Infrastructure Partners and Ironclad Energy Partners Announce Sale of Rochester District Energy Assets to SDCL Energy Efficiency Income Trust for $260mm Enterprise Value
2021-04-02 10:11 Takeda Completes Sale of Its Japan Consumer Health Care Business Unit to Blackstone
2021-03-01 19:09 Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
2021-02-09 10:46 Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience; Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS
2021-02-01 17:01 Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
2021-02-01 15:38 Takeda Completes Sale of TachoSil® to Corza Health
2020-12-21 15:24 Takeda Furthers Innovation-Focused Strategy in China with Sale of Select Non-Core Assets to Hasten for $322 million USD
2020-12-01 09:54 Takeda Completes Sale of Select OTC and Non-Core Assets to Celltrion in Asia Pacific